F. Douglas Boudinot
- Virology top 2%
- HIV Research and Treatment 29
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 44
- HIV/AIDS Research and Interventions 9
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 12
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 12
- Equine top 5%
-
- Drug Transport and Resistance Mechanisms 14
-
- Cytomegalovirus and herpesvirus research 10
-
- Biochemical and Molecular Research 7
-
- Analytical Methods in Pharmaceuticals 7
- Co-authors
- William J. JuskoRaymond F. SchinaziMichael R. UjhelyiChung K. ChuC. K. CHUJames M. GalloPrabhu RajagopalanHarold M. McClure
- Journals
- Advanced Drug Delivery Reviews (1 paper)Annals of the New York Academy of Sciences (2 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
F. Douglas Boudinot
96 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 123
- Virology 328
- Infectious Diseases 578
- Pharmacology 262
- Pharmacology 314
- Equine 25
Countries citing papers authored by F. Douglas Boudinot
This map shows the geographic impact of F. Douglas Boudinot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Douglas Boudinot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Douglas Boudinot more than expected).
Fields of papers citing papers by F. Douglas Boudinot
This network shows the impact of papers produced by F. Douglas Boudinot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Douglas Boudinot. The network helps show where F. Douglas Boudinot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside F. Douglas Boudinot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 83 | |
| 2 | 2004 | 1 | |
| 3 | 2003 | 1 | |
| 4 | 2002 | 5 | |
| 5 | 2000 | 136 | |
| 6 | 2000 | 22 | |
| 7 | 1999 | 13 | |
| 8 | 1997 | 12 | |
| 9 | 1997 | 19 | |
| 10 | 1996 | 83 | |
| 11 | 1996 | 3 | |
| 12 | 1996 | 4 | |
| 13 | 1996 | 155 | |
| 14 | 1996 | 29 | |
| 15 | 1995 | 11 | |
| 16 | 1990 | 36 | |
| 17 | 1990 | 15 | |
| 18 | 1990 | 14 | |
| 19 | 1989 | 2 | |
| 20 | 1989 | 34 |
About F. Douglas Boudinot
F. Douglas Boudinot is a scholar working on Virology, Infectious Diseases and Transplantation, having authored 97 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (44 papers), HIV Research and Treatment (29 papers), Drug Transport and Resistance Mechanisms (14 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Cytomegalovirus and herpesvirus research (10 papers), HIV/AIDS Research and Interventions (9 papers), Biochemical and Molecular Research (7 papers) and Analytical Methods in Pharmaceuticals (7 papers). The work is most often cited by research in Virology (328 citations), Infectious Diseases (578 citations) and Pharmacology (262 citations). F. Douglas Boudinot has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William J. Jusko, Raymond F. Schinazi, Michael R. Ujhelyi, Chung K. Chu, C. K. CHU, James M. Gallo, Prabhu Rajagopalan, Chung K. Chu, Harold M. McClure and Fred Wudl. Their work appears in journals such as Advanced Drug Delivery Reviews, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.